Combined overexpression of HIVEP3 and SOX9 predicts unfavorable biochemical recurrence- free survival in patients with prostate cancer
OncoTargets and Therapy2014Vol. 7, pp. 137–137
Citations Over TimeTop 12% of 2014 papers
Weide Zhong, Guoqiang Qin, Huichan He, Zhaodong Han, Yuxiang Liang, Sheng-Bang Yang, Yaqiang Huang, Liang Zhou, Hao Fu, Funeng Jiang, Jie-xian Li
Abstract
Our data offer the convincing evidence for the first time that a combined analysis of HIVEP3 and SOX9 may help to predict the tumor progression and prognosis of PCa patients. In particular, the overexpression of HIVEP3 in PCa might partly explain the poor prognosis of patients with an upregulation of SOX9.
Related Papers
- → Sex reversal following deletion of a single distal enhancer of Sox9(2018)249 cited
- → SOX8 Is Expressed during Testis Differentiation in Mice and Synergizes with SF1 to Activate the Amh Promoter in Vitro(2003)164 cited
- → Identification of Potential Predictor of Biochemical Recurrence in Prostate Cancer(2022)12 cited
- → Human sex reversal is caused by duplication or deletion of core enhancers upstream of SOX9(2019)2 cited
- → SOX9 and Campomelic Dysplasia and Sex Reversal(2008)